GPCR NewsAug 1, 20221 minGPCR Industry NewsSYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...August 2022 "We are proud to announce that SYnAbs is now officially accredited as a Research Tax Credit by the French Ministry of Higher...
GPCR NewsJul 1, 20221 minGPCR Industry NewsG.CLIPS biotech is 2 years old this month!July 2022 "G.CLIPS biotech is 2 years old today🎂. When I came this morning to work this is how I found my desk. So very grateful to the...
GPCR NewsJun 1, 20221 minGPCR Industry NewsGPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical DevelopmentJune 2022 "We’re delighted to welcome Dr Ed Brennan as our new Vice President, Head of Clinical Development. Dr Brennan has extensive...
GPCR NewsMar 1, 20221 minGPCR Industry NewsExscientia welcomes Richard J. Law, as their new Chief Business OfficerMarch 2022 "Congratulations to Richard J. Law, our newly named Chief Business Officer. Richard is the architect behind nearly all of...
GPCR NewsFeb 1, 20221 minGPCR Industry NewsAELIS PHARMA launches their IPO for €25 millionFebruary 2022 "We are proud to announce the success of our IPO! Thank you to our shareholders, both historical and new, for their trust....
GPCR NewsFeb 1, 20221 minGPCR Industry NewsInterAx Biotech AG and Boehringer Ingelheim take collaborate to unlock orphan targets leveraging ...February 2022 "InterAx Biotech AG and Boehringer Ingelheim take first steps towards collaborating to unlock orphan targets leveraging...